東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Drug repurposing = innovative approa...

Chella, Naveen.

FindBook

Google Book

Amazon

博客來

Drug repurposing = innovative approaches to drug discovery and development /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Drug repurposing/ edited by Naveen Chella, Om Prakash Ranjan, Amit Alexander.
其他題名:	innovative approaches to drug discovery and development /
其他作者:	Chella, Naveen.
出版者:	Singapore :Springer Nature Singapore : : 2024.,
面頁冊數:	xiii, 248 p. :ill., digital ;24 cm.
內容註:	Chapter 1. Drug repurposing: History, Significance, Benefits, Approaches and Challenges -- Chapter 2. Methodologies Adopted in Drug Repurposing -- Chapter 3. In silico methods used in drug repurposing -- Chapter 4. Role of artificial and machine learning in drug repurposing -- Chapter 5. Drug repurposing in cancer therapy -- Chapter 6. Drug repurposing in inflammatory disorders -- Chapter 7. Drug repurposing in CNS disorders -- Chapter 8. Reshaping the Therapeutic Landscape: Drug Repurposing for Emerging Infectious Diseases and Rare Diseases -- Chapter 9. Clinical trials on repurposed drugs: an overview -- Chapter 10. Intellectual Property Rights and Regulatory Considerations Throughout Drug Repurposing -- Chapter 11. Redirection to the Drug Discovery: Antidiabetic Drugs Repurposing in Cancer.
Contained By:	Springer Nature eBook
標題:	Drugs. -
電子資源:	https://doi.org/10.1007/978-981-97-5016-0
ISBN:	9789819750160

Drug repurposing = innovative approaches to drug discovery and development /
Drug repurposinginnovative approaches to drug discovery and development /[electronic resource] :edited by Naveen Chella, Om Prakash Ranjan, Amit Alexander. - Singapore :Springer Nature Singapore :2024. - xiii, 248 p. :ill., digital ;24 cm.

Chapter 1. Drug repurposing: History, Significance, Benefits, Approaches and Challenges -- Chapter 2. Methodologies Adopted in Drug Repurposing -- Chapter 3. In silico methods used in drug repurposing -- Chapter 4. Role of artificial and machine learning in drug repurposing -- Chapter 5. Drug repurposing in cancer therapy -- Chapter 6. Drug repurposing in inflammatory disorders -- Chapter 7. Drug repurposing in CNS disorders -- Chapter 8. Reshaping the Therapeutic Landscape: Drug Repurposing for Emerging Infectious Diseases and Rare Diseases -- Chapter 9. Clinical trials on repurposed drugs: an overview -- Chapter 10. Intellectual Property Rights and Regulatory Considerations Throughout Drug Repurposing -- Chapter 11. Redirection to the Drug Discovery: Antidiabetic Drugs Repurposing in Cancer.

This book offers an insightful exploration of drug repurposing, an innovative approach to drug discovery and development that has the potential to revolutionize the field of medicine. It begins with an introduction to drug repurposing and its history, providing a comprehensive overview of the subject. The readers will embark on a journey through the diverse landscape of drug repurposing strategies. From in silico methods of predicting drug-disease associations to experimental approaches to the integrations of artificial intelligence (AI) and machine learning (ML) in drug repurposing for validating repurposed candidates. The book also delves into the application of drug repurposing in various disease areas, including cancer, inflammatory disorders, and CNS disorders. It explores the potential hurdles involved in the regulatory aspects of the process. The book further covers drug products under clinical trials and provides an overview of the future perspectives of drug repurposing. With its detailed and informative content, this book is a must-read for researchers, clinicians, and healthcare professionals interested in the exciting field of drug repurposing.

ISBN: 9789819750160

Standard No.: 10.1007/978-981-97-5016-0doiSubjects--Topical Terms:

617161
Drugs.

LC Class. No.: RM301

Dewey Class. No.: 615.1

Drug repurposing = innovative approaches to drug discovery and development /
LDR:03051nmm a22003375a 4500 001 2387800
003 DE-He213
005 20240829130310.0
006 m d
007 cr nn 008maaau
008 250916s2024 si s 0 eng d
020 $a 9789819750160 $q (electronic bk.)
020 $a 9789819750153 $q (paper)
024 7 $a 10.1007/978-981-97-5016-0 $2 doi
035 $a 978-981-97-5016-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301
072 7 $a TCB $2 bicssc
072 7 $a SCI010000 $2 bisacsh
072 7 $a TCB $2 thema
082 0 4 $a 615.1 $2 23
090 $a RM301 $b .D794 2024
245 0 0 $a Drug repurposing $h [electronic resource] : $b innovative approaches to drug discovery and development / $c edited by Naveen Chella, Om Prakash Ranjan, Amit Alexander.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2024.
300 $a xiii, 248 p. : $b ill., digital ; $c 24 cm.
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1. Drug repurposing: History, Significance, Benefits, Approaches and Challenges -- Chapter 2. Methodologies Adopted in Drug Repurposing -- Chapter 3. In silico methods used in drug repurposing -- Chapter 4. Role of artificial and machine learning in drug repurposing -- Chapter 5. Drug repurposing in cancer therapy -- Chapter 6. Drug repurposing in inflammatory disorders -- Chapter 7. Drug repurposing in CNS disorders -- Chapter 8. Reshaping the Therapeutic Landscape: Drug Repurposing for Emerging Infectious Diseases and Rare Diseases -- Chapter 9. Clinical trials on repurposed drugs: an overview -- Chapter 10. Intellectual Property Rights and Regulatory Considerations Throughout Drug Repurposing -- Chapter 11. Redirection to the Drug Discovery: Antidiabetic Drugs Repurposing in Cancer.
520 $a This book offers an insightful exploration of drug repurposing, an innovative approach to drug discovery and development that has the potential to revolutionize the field of medicine. It begins with an introduction to drug repurposing and its history, providing a comprehensive overview of the subject. The readers will embark on a journey through the diverse landscape of drug repurposing strategies. From in silico methods of predicting drug-disease associations to experimental approaches to the integrations of artificial intelligence (AI) and machine learning (ML) in drug repurposing for validating repurposed candidates. The book also delves into the application of drug repurposing in various disease areas, including cancer, inflammatory disorders, and CNS disorders. It explores the potential hurdles involved in the regulatory aspects of the process. The book further covers drug products under clinical trials and provides an overview of the future perspectives of drug repurposing. With its detailed and informative content, this book is a must-read for researchers, clinicians, and healthcare professionals interested in the exciting field of drug repurposing.
650 0 $a Drugs. $3 617161
650 0 $a Drugs $x Design. $3 664528
650 1 4 $a Drug Delivery. $3 3531319
650 2 4 $a Drug Safety and Pharmacovigilance. $3 2108855
650 2 4 $a Diseases. $3 618693
700 1 $a Chella, Naveen. $3 3752482
700 1 $a Ranjan, Om Prakash. $3 3752483
700 1 $a Alexander, Amit. $3 3723663
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-97-5016-0
950 $a Biomedical and Life Sciences (SpringerNature-11642)